vimarsana.com
Home
Live Updates
Antitrust + Competition Life Sciences Quarterly Update - Q2
Antitrust + Competition Life Sciences Quarterly Update - Q2
Antitrust + Competition Life Sciences Quarterly Update - Q2 2022 | Goodwin
Although the second quarter did not feature any life sciences enforcement action by the FTC, there was plenty of news in and around the space. The FTC held a detailed “virtual...
Related Keywords
California ,
United States ,
Canada ,
United Kingdom ,
Lina Khan ,
Merck Co ,
Us District Court ,
Seagen Inc ,
Multilateral Pharmaceutical Merger Task Force ,
Pfizer ,
While The Task ,
Unlimited Inc ,
Meta Platforms Inc ,
Competition Technology Quarterly Update ,
Allergan ,
Bristol Myers Squibb ,
Pharma Merger Task Force Presses Forward ,
State Attorneys General ,
Task Force ,
Ominous Sign ,
Northern District ,
Meta Platforms ,
Within Unlimited ,
Trends We Are ,
Potential Acquisition ,
Global Blood Therapeutics ,
Merck Seagen Transaction ,
Bristol Myers ,
Democratic Commissioners Chopra ,